ClinConnect ClinConnect Logo
Search / Trial NCT00001604

Genetic Linkage Studies of Stuttering

Launched by NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS (NIDCD) · Nov 3, 1999

Trial Information

Current as of March 21, 2025

Completed

Keywords

Dna Samples Stuttering Dna Testing Statistical Analysis Genetic Analysis Natural History

ClinConnect Summary

A primary goal of this study is to ascertain regions of the human genome which show genetic linkage to stuttering. Genetic linkage will be determined by first obtaining genomic DNA from both affected and unaffected adults and children from families containing pairs of individuals who stutter as adults. Individuals who stutter from genetically isolated populations will also be sampled. Phenotype will be assigned by a speech-language pathologist, and DNA samples will be obtained from affected and unaffected family members from 2 cc. of saliva or from 20 cc. of blood. These DNA samples will th...

Gender

ALL

Eligibility criteria

  • * INCLUSION CRITERIA:
  • Individuals age 8 and older.
  • Individuals age 6-8 with a family history of persistent stuttering
  • Have stuttering that persists for a period of 6 months or more or are a family member of that person
  • For the Phase 2 imaging studies, we will be enrolling up to 25 healthy volunteers to be controls
  • EXCLUSION CRITERIA:
  • Stuttering only as a young child (before age 5) with no other family members who stutter
  • Inability to provide informed consent or have a parent/guardian to provide consent
  • Development of stuttering following trauma to the central nervous system.
  • Chronic medical conditions that prevent informed consent or clear evaluation of stuttering, including stroke, dementia, and degenerative neurological disease.
  • Inability to travel to the NIH Clinical Center for Phase 2

Trial Officials

Joshua Levy, M.D.

Principal Investigator

National Institute on Deafness and Other Communication Disorders (NIDCD)

About National Institute On Deafness And Other Communication Disorders (Nidcd)

The National Institute on Deafness and Other Communication Disorders (NIDCD) is a prominent agency within the National Institutes of Health (NIH) dedicated to advancing research and understanding of hearing, balance, taste, smell, voice, speech, and language disorders. Through rigorous clinical trials and innovative research initiatives, the NIDCD aims to improve the diagnosis, treatment, and prevention of communication disorders, ultimately enhancing the quality of life for individuals affected by these conditions. The institute fosters collaboration among researchers, healthcare professionals, and patients to translate scientific discoveries into effective clinical practices and public health strategies.

Locations

Bethesda, Maryland, United States

Bethesda, Maryland, United States

Saitama, , Japan

Lahore, , Pakistan

People applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials